a manufacturer of products for breast cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with ABOS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then ABOS could also see price increases.
Ticker / NAME | Correlation To ATOS | 1D Price Change % | ||
---|---|---|---|---|
ATOS | 100% | -2.19% | ||
ABOS - ATOS | 34% Loosely correlated | -10.58% | ||
ALLO - ATOS | 34% Loosely correlated | -4.56% | ||
DNA - ATOS | 33% Poorly correlated | -8.82% | ||
ELVN - ATOS | 33% Poorly correlated | +1.46% | ||
SRRK - ATOS | 33% Poorly correlated | -2.15% | ||
More |
Ticker / NAME | Correlation To ATOS | 1D Price Change % |
---|---|---|
ATOS | 100% | -2.19% |
cancer theme (87 stocks) | 34% Loosely correlated | +0.89% |
medical research theme (128 stocks) | 26% Poorly correlated | +0.46% |
medical service theme (156 stocks) | 26% Poorly correlated | +0.31% |